Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation
S Ueshima, D Hira, Y Kimura, R Fujii… - British journal of …, 2018 - Wiley Online Library
Aims This study aimed to analyse the effects of genetic polymorphisms in drug transporters
and metabolizing enzymes, and clinical laboratory data on the pharmacokinetic parameters …
and metabolizing enzymes, and clinical laboratory data on the pharmacokinetic parameters …
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry
F Gabriele, M Foschi, F Conversi… - … Journal of Stroke, 2023 - journals.sagepub.com
Background: Recent years have seen a change in the use of anticoagulants in the general
population due to the availability of direct oral anticoagulants (DOACs) as an alternative to …
population due to the availability of direct oral anticoagulants (DOACs) as an alternative to …
Time trends in intracerebral hemorrhage associated with oral anticoagulation and its risks factors in Spain from 2008 to 2015
S Quintas, G Zapata-Wainberg, S Arias-Rivas… - European …, 2021 - karger.com
Background: Intracerebral hemorrhage (ICH) is 7-to 10-fold higher in anticoagulated
patients. Given the more extended use of oral anticoagulants, an increase in the prevalence …
patients. Given the more extended use of oral anticoagulants, an increase in the prevalence …
[HTML][HTML] Differences in adverse event reporting rates of therapeutic failure between two once-daily extended-release methylphenidate medications in Canada …
L Park-Wyllie, J van Stralen, G Castillon… - Clinical Therapeutics, 2017 - Elsevier
Purpose Our study evaluated adverse events of therapeutic failure (and specifically reduced
duration of action) with the use of a branded product, Osmotic Release Oral System (OROS) …
duration of action) with the use of a branded product, Osmotic Release Oral System (OROS) …
Direct oral anticoagulants: a practical guide for the emergency physician
K Hogg, A Panag, A Worster… - European Journal of …, 2016 - journals.lww.com
The direct oral anticoagulants (DOACs) are the mainstay for stroke prophylaxis in
nonvalvular atrial fibrillation and treatment of acute venous thrombosis. They are attractive …
nonvalvular atrial fibrillation and treatment of acute venous thrombosis. They are attractive …
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study
E Admassie, L Chalmers, LR Bereznicki - European journal of clinical …, 2017 - Springer
Purpose Limited data are available from the Australian setting regarding bleeding in patients
with atrial fibrillation (AF) receiving antithrombotic therapy. We aimed to investigate the …
with atrial fibrillation (AF) receiving antithrombotic therapy. We aimed to investigate the …
Barriers to continued administration of direct oral anticoagulants between acute hospital and subacute or chronic hospitals and geriatric health services facilities in …
H Akiyama, S Nukui, Y Hasegawa - Hospital Practice, 2019 - Taylor & Francis
Objectives: To investigate whether direct oral anticoagulant (DOAC) therapy at acute
hospitals is continued after transfer to subacute or chronic hospitals and geriatric health …
hospitals is continued after transfer to subacute or chronic hospitals and geriatric health …
The Tasmanian atrial fibrillation study: transition to direct oral anticoagulants
EA Alamneh - 2018 - figshare.utas.edu.au
Atrial fibrillation (AF) is the most common cardiac dysrhythmia in the world, mainly affecting
elderly individuals. The incidence and prevalence of AF are increasing globally owing to an …
elderly individuals. The incidence and prevalence of AF are increasing globally owing to an …
